Pharmanutra SpA
MIL:PHN

Watchlist Manager
Pharmanutra SpA Logo
Pharmanutra SpA
MIL:PHN
Watchlist
Price: 58.5 EUR 2.81% Market Closed
Market Cap: 566.3m EUR
Section:
 

Relative Value

The Relative Value of one PHN stock under the Base Case scenario is 48.69 EUR. Compared to the current market price of 58.5 EUR, Pharmanutra SpA is Overvalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHN Relative Value
Base Case
48.69 EUR
Overvaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
80
vs Industry
15
Median 3Y
3.5
Median 5Y
4.6
Industry
1.1
Forward
4.2
More Details
23.8
P/E
P/E
Price to Earnings
23.8
vs History
63
vs Industry
25
Median 3Y
23.1
Median 5Y
25.6
Industry
17.8
Forward
28.7
More Details
45.5
P/OCF
P/OCF
Price to OCF
45.5
vs History
17
vs Industry
20
Median 3Y
38.8
Median 5Y
35.1
Industry
11.6
More Details
171.9
P/FCFE
P/FCFE
Price to FCFE
171.9
vs History
6
vs Industry
19
Median 3Y
45.4
Median 5Y
40.4
Industry
15.6
More Details
9.2
P/B
P/B
Price to Book Value
9.2
vs History
65
vs Industry
4
Median 3Y
9
Median 5Y
9.5
Industry
1.6
More Details
3.2
EV/S
EV/S
Enterprise Value to Sales
3.2
vs History
80
vs Industry
16
Median 3Y
3.5
Median 5Y
4.5
Industry
1.2
Forward
4.2
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
80
vs Industry
50
Median 3Y
3.6
Median 5Y
4.7
Industry
4
More Details
13.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.2
vs History
77
vs Industry
29
Median 3Y
13.5
Median 5Y
16.3
Industry
10.5
Forward
16.4
More Details
14.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.7
vs History
74
vs Industry
31
Median 3Y
14.6
Median 5Y
17.8
Industry
13.6
Forward
18.9
More Details
45.6
EV/OCF
EV/OCF
Enterprise Value to OCF
45.6
vs History
15
vs Industry
21
Median 3Y
38.6
Median 5Y
34.1
Industry
12.5
More Details
68.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
68.7
vs History
11
vs Industry
19
Median 3Y
27.2
Median 5Y
32.7
Industry
15.9
More Details
6.7
EV/IC
EV/IC
Enterprise Value to IC
6.7
vs History
71
vs Industry
7
Median 3Y
6.5
Median 5Y
7.7
Industry
1.2
More Details

Multiples Across Competitors

PHN Competitors Multiples
Pharmanutra SpA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Pharmanutra SpA
MIL:PHN
561.1m EUR 3.2 23.8 13.2 14.7
FR
L'Oreal SA
PAR:OR
205.6B EUR 4.7 33.6 19 23.2
UK
Unilever PLC
LSE:ULVR
116.3B GBP 2.2 23.3 201.7 234.4
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.6T INR 8.7 51.2 37.1 41.1
UK
HALEON PLC
LSE:HLN
33B GBP 2.9 22.9 13.8 15.7
US
Estee Lauder Companies Inc
NYSE:EL
41B USD 2.8 -44.1 22.1 36.6
DE
Beiersdorf AG
XETRA:BEI
20.9B EUR 2.1 23.7 11.7 15
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.7 11.3 17.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 8.5 69 42.9 47
IN
Dabur India Ltd
NSE:DABUR
925.9B INR 7.2 51.2 38.4 47.6
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 855.7 -4 624.4 -6 373.4 -6 360.4
P/E Multiple
Earnings Growth PEG
IT
Pharmanutra SpA
MIL:PHN
Average P/E: 35.8
23.8
19%
1.3
FR
L'Oreal SA
PAR:OR
33.6
8%
4.2
UK
Unilever PLC
LSE:ULVR
23.3
15%
1.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
51.2
8%
6.4
UK
HALEON PLC
LSE:HLN
22.9
12%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -44.1 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
23.7
8%
3
JP
Kao Corp
TSE:4452
23.7
13%
1.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
69
19%
3.6
IN
Dabur India Ltd
NSE:DABUR
51.2
12%
4.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IT
Pharmanutra SpA
MIL:PHN
Average EV/EBITDA: 41.1
13.2
14%
0.9
FR
L'Oreal SA
PAR:OR
19
5%
3.8
UK
Unilever PLC
LSE:ULVR
201.7
1%
201.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
37.1
8%
4.6
UK
HALEON PLC
LSE:HLN
13.8
4%
3.5
US
Estee Lauder Companies Inc
NYSE:EL
22.1
15%
1.5
DE
Beiersdorf AG
XETRA:BEI
11.7
-1%
N/A
JP
Kao Corp
TSE:4452
11.3
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
42.9
13%
3.3
IN
Dabur India Ltd
NSE:DABUR
38.4
11%
3.5
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IT
Pharmanutra SpA
MIL:PHN
Average EV/EBIT: 49.2
14.7
15%
1
FR
L'Oreal SA
PAR:OR
23.2
6%
3.9
UK
Unilever PLC
LSE:ULVR
234.4
1%
234.4
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
41.1
9%
4.6
UK
HALEON PLC
LSE:HLN
15.7
4%
3.9
US
Estee Lauder Companies Inc
NYSE:EL
36.6
25%
1.5
DE
Beiersdorf AG
XETRA:BEI
15
-2%
N/A
JP
Kao Corp
TSE:4452
17.3
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
47
13%
3.6
IN
Dabur India Ltd
NSE:DABUR
47.6
11%
4.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 360.4 N/A N/A

See Also

Summary
PHN intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHN stock valuation using valuation multiples.
Wall Street Estimates
PHN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.